MIXED DYSLIPIDEMIA
Clinical trials for MIXED DYSLIPIDEMIA explained in plain language.
Never miss a new study
Get alerted when new MIXED DYSLIPIDEMIA trials appear
Sign up with your email to follow new studies for MIXED DYSLIPIDEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Two drugs beat one in fight against bad cholesterol
Disease control CompletedThis study tested whether a combination of two cholesterol-lowering drugs (DW5421A/DW5421B) works better than one of the drugs alone (DW5421A). It involved 184 adults with high cholesterol or mixed lipid disorders. The main goal was to see which treatment lowered 'bad' LDL choles…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE3 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New cholesterol drug shows promise in Mid-Stage trial
Disease control CompletedThis study tested whether a new drug called plozasiran (ARO-APOC3) could safely lower unhealthy fats and cholesterol in the blood of adults with mixed dyslipidemia. 353 participants were randomly assigned to receive either the drug or a placebo for 48 weeks while following a reco…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Experimental injection aims to tame dangerous blood fats
Disease control CompletedThis study tested whether an investigational drug called ARO-ANG3, given as injections under the skin, could safely lower unhealthy levels of fats in the blood (mixed dyslipidemia). It involved 204 adults who were already on stable cholesterol medication. Participants received ei…
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
First human test for new cholesterol pill
Knowledge-focused CompletedThis was an early safety study to see how the body absorbs and processes two forms of a new drug candidate, DW5124, intended to treat mixed dyslipidemia (a cholesterol and fat disorder). It involved 55 healthy adult volunteers to check for side effects and see if taking the drug …
Matched conditions: MIXED DYSLIPIDEMIA
Phase: PHASE1 • Sponsor: Daewon Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Massive 12,000-Patient review shows how well new cholesterol shots work
Knowledge-focused CompletedThis study looked back at the health records of nearly 12,000 adults in China with high cholesterol. Researchers wanted to see how well two newer types of injectable cholesterol medicines worked for people in everyday life, outside of a controlled trial. They compared the effecti…
Matched conditions: MIXED DYSLIPIDEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC